Merck Neuroscience / AI Grant 2026
Merck (Germany)
HIGH
T4
Neuropharm/CCT
Strategy Notes
Platform maps onto AI in CNS drug process development. Niche topic categories genuinely lower competition. Draft the application around the platform architecture, not the CCT papers. Also tracked in Merck In Silico Cup context.
Key Materials
Application around Neuropharm Simulation Platform architecture. Circuit-level simulation as process development tool.
Gate / Eligibility
Niche calls for AI in cell culture, process development, and in-vitro models for neuroinflammatory diseases. No lab access required for computational tier.